Effect of Sex Hormones on Crystal Formation in a Stone-forming Rat Model

Urology

Volumn 75, Issue 4, 2010, Pages 907-913

  Yoshioka, Iwao ^a   Tsujihata, Masao ^a   Momohara, Chikahiro ^a   Akanae, Wongsawat ^a   Nonomura, Norio ^a   Okuyama, Akihiko ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ALANINE GLYOXYLATE AMINOTRANSFERASE; ANTIOXIDANT; CALCITRIOL; COPPER ZINC SUPEROXIDE DISMUTASE; ESTRADIOL; HYDROXY ACID OXIDASE A; MANGANESE SUPEROXIDE DISMUTASE; OXALIC ACID; SEX HORMONE; TESTOSTERONE;

ADOLESCENT; AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; MALE; NEPHROLITHIASIS; NONHUMAN; ORCHIECTOMY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; STONE FORMATION; SUSTAINED DRUG RELEASE; URINARY EXCRETION; UROLITHIASIS;

ANIMALS; CRYSTALLIZATION; DISEASE MODELS, ANIMAL; ESTRADIOL; FEMALE; MALE; RATS; RATS, WISTAR; TESTOSTERONE; UROLITHIASIS;

EID: 77950300879     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.09.094     Document Type: Article

References (26)

1. Yasui T., Iguchi M., Suzuki S., et al. Prevalence and epidemiological characteristics of urolithiasis in Japan: national trends between 1965 and 2005. Urology 71 (2008) 209-213
2. Lee Y.H., Huang W.C., Chiang H., et al. Testosterone enhances whereas estrogen inhibits calcium oxalate stone formation in ethylene glycol treated rats. J Urol 156 (1996) 502-505
3. Iguchi M., Takamura C., Umekawa T., et al. Inhibitory effects of female sex hormones on urinary stone formation in rats. Kidney Int 56 (1999) 479-485
4. Yoshihara H., Yamaguchi S., and Yachiku S. Effect of sex hormones on oxalate-synthesizing enzymes in male and female rat livers. J Urol 161 (1999) 668-673
5. Fan J., Glass M.A., and Chandhoke P.S. Effect of castration and finasteride on urinary oxalate excretion in male rats. Urol Res 26 (1998) 71-75
6. Fan J., Chandhoke P.S., and Grampsas S.A. Role of sex hormones in experimental calcium oxalate nephrolithiasis. J Am Soc Nephrol 10 (1999) S376-S380
7. Khan S.R., and Kok D.J. Modulators of urinary stone formation. Front Biosci 9 (2004) 1450-1482
8. Dey J., Creighton A., Lindberg J.S., et al. Estrogen replacement increased the citrate and calcium excretion rates in postmenopausal women with recurrent urolithiasis. J Urol 167 (2002) 169-171
9. Gu S., Ripp S.L., Prough R.A., et al. Dehydroepiandrosterone affects the expression of multiple genes in rat liver including 11 beta-hydroxysteroid dehydrogenase type 1: a cDNA array analysis. Mol Pharmacol 63 (2003) 722-731
10. Murray M.S., Holmes R.P., and Lowther W.T. Active site and loop 4 movements within human glycolate oxidase: implications for substrate specificity and drug design. Biochemistry 47 (2008) 2439-2449
11. Nishijima S., Sugaya K., Hokama S., et al. Effect of dehydroepiandrosterone on oxalate metabolism in rats. Front Biosci 9 (2004) 1360-1364
12. Khan S.R. Hyperoxaluria-induced oxidative stress and antioxidants for renal protection. Urol Res 33 (2005) 349-357
13. Khan S.R. Renal tubular damage/dysfunction: key to the formation of kidney stones. Urol Res 34 (2006) 86-91
14. Sullivan J.C., Sasser J.M., and Pollock J.S. Sexual dimorphism in oxidant status in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 292 (2007) R764-R768
15. Dantas A.P., Franco Mdo C., Silva-Antonialli M.M., et al. Gender differences in superoxide generation in microvessels of hypertensive rats: role of NAD(P)H-oxidase. Cardiovasc Res 61 (2004) 22-29
16. Li P., Ferrario C.M., Ganten D., et al. Chronic estrogen treatment in female transgenic (mRen2)27 hypertensive rats augments endothelium-derived nitric oxide release. Am J Hypertens 10 (1997) 662-670
17. Tei N., Tsujihata M., Tsujikawa K., et al. Hepatocyte growth factor has protective effects on crystal-cell interaction and crystal deposits. Urology 67 (2006) 864-869
18. Kakimoto M., Inoguchi T., Sonta T., et al. Accumulation of 8-hydroxy-2′-deoxyguanosine and mitochondrial DNA deletion in kidney of diabetic rats. Diabetes 51 (2002) 1588-1595
19. Etoh T., Inoguchi T., Kakimoto M., et al. Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatment. Diabetologia 46 (2003) 1428-1437
20. Tanaka T., Nishiyama Y., Okada K., et al. Induction and nuclear translocation of thioredoxin by oxidative damage in the mouse kidney: independence of tubular necrosis and sulfhydryl depletion. Lab Invest 77 (1997) 145-155
21. Monico C.G., Persson M., Ford G.C., et al. Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II. Kidney Int 62 (2002) 392-400
22. Tam N.N., Gao Y., Leung Y.K., et al. Androgenic regulation of oxidative stress in the rat prostate: involvement of NAD(P)H oxidases and antioxidant defense machinery during prostatic involution and regrowth. Am J Pathol 163 (2003) 2513-2522
23. Calò L.A., and Davis P.A. NADPH oxidase subunits (NOX-1, p22phox, Rac-1) and tacrolimus-induced nephrotoxicity in a rat renal transplant model. Nephrol Dial Transplant 22 (2007) 2402 author reply 2403
24. Schrader M., and Fahimi H.D. Mammalian peroxisomes and reactive oxygen species. Histochem Cell Biol 122 (2004) 383-393
25. Recalcati S., Tacchini L., Alberghini A., et al. Oxidative stress-mediated down-regulation of rat hydroxyacid oxidase 1, a liver-specific peroxisomal enzyme. J Hepatol 38 (2003) 1159-1166
26. Tsujihata M., Momohara C., Yoshioka I., et al. Atorvastatin inhibits renal crystal retention in a rat stone forming model. J Urol 180 (2008) 2212-2217